Exact Sciences Corp (EXAS) Stock Price

EXASStock

$0.00+53.14%52W

Market Cap—

P/E—

PEG Ratio—

Div yield—

Beta-0.40

EXAS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-25.78%

Price vs S&P 500 (4W)6.43%

VGM Score48.64

P/CF (Annual)40.75x

Book Value / Share (Quarterly)$12.58

P/TBV (Annual)13.02x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)15.92%

Cash Flow / Share (Quarterly)$1.48

Price vs S&P 500 (YTD)8.19%

Gross Margin (TTM)69.69%

Net Profit Margin (TTM)-6.40%

EPS (TTM)$-1.10

10-Day Avg Trading Volume4.06M

EPS Excl Extra (TTM)$-1.10

Revenue Growth (5Y)16.84%

EPS (Annual)$-1.10

ROI (Annual)-4.39%

Gross Margin (Annual)69.69%

Net Profit Margin (5Y Avg)-23.09%

Cash / Share (Quarterly)$5.06

Revenue Growth QoQ (YoY)23.12%

ROA (Last FY)-3.55%

Revenue Growth TTM (YoY)17.69%

EBITD / Share (TTM)$-0.43

ROE (5Y Avg)-19.21%

Operating Margin (TTM)-6.35%

Cash Flow / Share (Annual)$1.48

P/B Ratio8.34x

P/B Ratio (Quarterly)8.03x

Net Income / Employee (Annual)$-29,300

EV / Revenue (TTM)6.59x

Net Interest Coverage (TTM)-15.18x

ROA (TTM)-3.57%

EPS Incl Extra (Annual)$-1.10

Current Ratio (Annual)2.43x

Quick Ratio (Quarterly)1.97x

3-Month Avg Trading Volume4.50M

52-Week Price Return53.14%

EV / Free Cash Flow (Annual)75.98x

Revenue / Employee (TTM)$457,300

Tangible BV / Share (Quarterly)$7.76

P/S Ratio (Annual)6.17x

Asset Turnover (Annual)0.55x

52-Week High$104.98

Operating Margin (5Y Avg)-25.81%

EPS Excl Extra (Annual)$-1.10

CapEx CAGR (5Y)-15.13%

Tangible BV CAGR (5Y)1.30%

26-Week Price Return-19.53%

Quick Ratio (Annual)1.97x

13-Week Price Return3.10%

Total Debt / Equity (Annual)0.97x

Current Ratio (Quarterly)2.43x

Enterprise Value$21.41B

Revenue / Share Growth (5Y)11.76%

Asset Turnover (TTM)0.56x

Book Value / Share Growth (5Y)-2.15%

Revenue / Employee (Annual)$457,300

Inventory Turnover (Annual)5.99x

Pretax Margin (Annual)-6.28%

Cash / Share (Annual)$5.06

3-Month Return Std Dev3.30%

Gross Margin (5Y Avg)71.24%

Net Income / Employee (TTM)$-29,300

ROE (Last FY)-8.66%

Net Interest Coverage (Annual)-23.91x

EPS Basic Excl Extra (Annual)$-1.10

P/FCF (TTM)70.98x

Receivables Turnover (TTM)11.86x

EV / Free Cash Flow (TTM)75.98x

Total Debt / Equity (Quarterly)0.97x

EPS Incl Extra (TTM)$-1.10

Receivables Turnover (Annual)11.86x

ROI (TTM)-4.35%

P/S Ratio (TTM)6.17x

Pretax Margin (5Y Avg)-25.99%

Revenue / Share (Annual)$17.21

Tangible BV / Share (Annual)$7.76

Forward P/E582.83x

Price vs S&P 500 (52W)35.27%

Year-to-Date Return3.30%

5-Day Price Return1.02%

EPS Normalized (Annual)$-1.10

ROA (5Y Avg)-8.60%

Net Profit Margin (Annual)-6.40%

Month-to-Date Return1.48%

Cash Flow / Share (TTM)$-0.44

EBITD / Share (Annual)$-0.43

Operating Margin (Annual)-6.35%

LT Debt / Equity (Annual)0.97x

P/CF (TTM)40.75x

ROI (5Y Avg)-10.23%

LT Debt / Equity (Quarterly)0.97x

EPS Basic Excl Extra (TTM)$-1.10

P/TBV (Quarterly)13.02x

P/B Ratio (Annual)8.03x

Inventory Turnover (TTM)5.99x

Pretax Margin (TTM)-6.28%

Book Value / Share (Annual)$12.58

Price vs S&P 500 (13W)7.56%

Beta-0.40x

P/FCF (Annual)71.07x

Revenue / Share (TTM)$17.11

ROE (TTM)-8.51%

52-Week Low$57.75

vGradeF

gGradeB

mGradeB

vgmGradeC

EXAS Analyst Recommendations

Apr 2026

May 2026

Jun 2026

Jul 2026

3.34

Industry Peers — Health Services(30)

Symbol	Value Score	Growth Score	Momentum Score	P/E Ratio (Annual)	Revenue Growth TTM (YoY)	Operating Margin (TTM)	ROE (TTM)	Price
EXASExact Sciences Corp	F	B	B	—	17.7%	-6.3%	-8.5%	$0.00
NTRANatera, Inc. Common Stock	F	A	A	—	37.8%	-10.7%	-11.7%	$393.44
DGXQuest Diagnostics Inc.	C	D	B	26.1x	9.9%	14.1%	14.5%	$235.00
LHLabcorp Holdings Inc.	C	D	B	29.4x	6.4%	10.4%	11.6%	$317.95
GHGuardant Health, Inc. Common Stock	F	A	B	—	42.7%	-40.2%	-246.6%	$158.60
CAICaris Life Sciences, Inc. Common Stock	F	A	B	—	38.5%	12.7%	18.8%	$30.56
RDNTRadNet, Inc. Common Stock	D	C	C	1779.3x	18.9%	3.0%	-1.9%	$68.80
GRALGRAIL, Inc. Common Stock	D	B	B	—	23.1%	-338.4%	-15.9%	$117.81
BLLNBillionToOne, Inc. Class A Common Stock	F	F	C	621.1x	—	10.9%	8.9%	$98.12
VCYTVeracyte, Inc.	D	B	C	52.2x	17.3%	19.6%	8.6%	$43.12
CDNACareDx, Inc.	D	B	A	18.3x	34.4%	23.6%	32.8%	$64.00
CELCCelcuity Inc. Common Stock	—	—	D	—	—	—	-244.6%	$56.58
FTREFortrea Holdings Inc. Common Stock	C	F	A	—	-2.1%	-0.4%	-15.5%	$22.49
PSNLPersonalis, Inc. Common Stock	F	D	B	—	-13.3%	-164.1%	-46.5%	$15.65
FRNMFreenome, Inc. Common stock	—	F	F	1507.5x	—	—	-0.9%	$11.75
LMRILumexa Imaging Holdings, Inc. Common Stock	C	C	C	—	—	8.2%	-8.7%	$10.78
CSTLCastle Biosciences, Inc. Common Stock	D	B	B	47.3x	3.2%	-9.0%	-4.2%	$31.96
FLGTFulgent Genetics, Inc. Common Stock	C	D	C	—	6.8%	-37.8%	-7.9%	$19.81
YDESYD Bio Limited Ordinary Shares	—	—	C	—	—	—	149.8%	$5.92
BDSXBiodesix, Inc. Common Stock	D	B	B	—	34.5%	-20.0%	-164.9%	$23.66
XGNExagen Inc. Common Stock	D	C	B	—	20.8%	-18.6%	-121.6%	$7.72
BNRBurning Rock Biotech Limited American Depositary Shares	C	F	B	—	-6.7%	-13.0%	-13.0%	$12.90
PCSCPerceptive Capital Solutions Corp Class A Ordinary Shares	—	F	C	147.2x	—	—	0.1%	$12.19
SERASera Prognostics, Inc. Class A Common Stock	D	C	C	—	-35.2%	-53282.9%	-46.7%	$2.06
MDXHMDxHealth SA Ordinary Shares	C	D	F	—	-5.2%	-16.6%	-305.0%	$0.21
AMSAmerican Shared Hospital Services	A	C	C	4.1x	4.0%	-11.8%	-7.5%	$1.28
ADVBAdvanced Biomed Inc. Common Stock	A	—	D	—	—	—	83.9%	$3.98
ACONAclarion, Inc. Common Stock	—	B	F	—	33.1%	-11592.2%	-59.3%	$1.85
BGLCBioNexus Gene Lab Corp Common stock	B	F	F	—	-67.1%	-81.8%	-32.9%	$1.20
ACONWAclarion, Inc. Warrant	—	—	D	—	—	—	—	$0.03
YDESWYD Bio Limited Warrants	—	—	B	—	—	—	—	$0.60

About Exact Sciences Corp

Exact Sciences develops cancer screening and diagnostic tests for the United States and international markets. Its primary offerings include Cologuard, a noninvasive stool-based DNA test for colorectal cancer screening, and Oncotype DX, a precision oncology suite providing tissue-based genomic testing for cancer risk assessment and treatment guidance. The company is expanding its portfolio with OncoExTra, a liquid-based genomic profiling test, and a pipeline of blood-based solutions for cancer detection and molecular residual disease monitoring.